Physician profile
Paul J Betschart
NPI 1639270044
$9,705.14
in general payments reported to CMS, 2019-2025
14 companies · $5,946 in 2025
The $5,946 reported for 2025 was more than what 97% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $89.95 · 2021: $900 · 2022: $808 · 2023: $1,597 · 2024: $93.69 · 2025: $5,946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,190 · Food and Beverage: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,190.25 |
| Food and Beverage | $1,445.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $8,254.39 | 2021-2025 | |
| Smith+Nephew, INC. | $494.96 | 2019-2025 | Stravix, Oasis, Grafix |
| Organogenesis INC. | $294.93 | 2019-2022 | |
| Averitas Pharma INC. | $144.57 | 2023 | Qutenza |
| Shockwave Medical, INC | $109.75 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Wright Medical Technology, INC. | $104.95 | 2019 | |
| Stryker Corporation | $96.39 | 2021-2024 | Ortholoc 2 Lapifuse, Dart-Fire, Phalinx |
| Gramercy Extremity Orthopedics LLC | $76.46 | 2021 | |
| Bioventus LLC | $37.59 | 2020-2022 | |
| Djo, LLC | $22.45 | 2019 | |
| Grt US Holding, INC. | $21.62 | 2021 | |
| Depuy Synthes Sales INC. | $18.55 | 2024 | Dynacord, Healix Knotless Peek, Speedtrap |
| Checkpoint Surgical, INC | $14.76 | 2023 | Checkpoint Stimulators |
| Misonix INC | $13.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Betschart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.